ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

JPMORGAN CHASE & CO's Holding History (CIK: 0000019617)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,203,000 Value ($000) $1,771 Avg Close — Range —
Q3 2025
Shares 3,305,000 Value ($000) $5,366 Avg Close — Range —
Q2 2025
Shares 5,503,000 Value ($000) $7,096 Avg Close — Range —
Q1 2025
Shares 5,550,000 Value ($000) $6,411 Avg Close — Range —
Q4 2024
Shares 4,272,000 Value ($000) $4,568 Avg Close — Range —
Q3 2024
Shares 3,250,000 Value ($000) $3,818 Avg Close — Range —
Q2 2024
Shares 6,877,000 Value ($000) $7,415 Avg Close — Range —
Q1 2024
Shares 1,175,000 Value ($000) $1,108 Avg Close — Range —
Q4 2023
Shares 115,000 Value ($000) $114 Avg Close — Range —
Q3 2023
Shares 530,000 Value ($000) $492 Avg Close — Range —